Document is current
Any future updates will be listed below
-
Authors
Bergh, Cecilia https://orcid.org/0000-0002-0853-7545
Landberg, Rikard
Andersson, Kristina
Heyman-Lindén, Lovisa
Rascón, Ana
Magnuson, Anders
Khalili, Payam
Kåregren, Amra
Nilsson, Johan
Pirazzi, Carlo
Erlinge, David
Fröbert, Ole
-
Funding
Funding for this research was provided by:
KK-Foundation (20190102)
Hjärt-Lungfonden (20190513)
Region Örebro län (OLL-879481 and OLL-935023, OLL-833051)
Regionala forskningsrådet Örebro/Uppsala (RFR-931350)
Dr P Håkanssons Foundation, Eslöv (2019. 2020)
Örebro University
- License Information
-
More Information
Article History
Received: 23 November 2020
Accepted: 22 April 2021
First Online: 10 May 2021
Declarations
:
: The study will be conducted in accordance with the protocol and ethical principles of the Declaration of Helsinki as adapted by the 18th World Medical Assembly in Helsinki, Finland, in 1964 and subsequent versions. The trial was approved by the Swedish Ethical Review board (dnr 2018/325) with approved amendments (dnr 2019-06520, dnr 2020-05690, dnr 2021-00459). All patients will provide written consent for participation and publication of trial data.
: Not applicable.
: KA and AR are, apart from their academic activities, also Senior Scientist and CSO, respectively, at Glucanova AB. AR, KA, and LHL are involved in the study product conceptualization, development, and production but not in data collection or data analysis.
